Delayed iron improves iron status without altering malaria risk in severe malarial anemia

Area of Science:

• Pediatric Infectious Diseases
• Nutritional Anemia
• Malaria Research

Background:

• WHO guidelines suggest concurrent iron and antimalarial treatment for children with malaria and iron deficiency.
• Iron absorption and utilization may be compromised during acute malaria episodes.

Purpose of the Study:

• To evaluate if delaying iron treatment for 28 days post-antimalarial therapy improves iron status and reduces malaria risk in children with severe malaria and iron deficiency.

Main Methods:

• A randomized clinical trial involving Ugandan children aged 18 months to 5 years with cerebral malaria (CM) or severe malarial anemia (SMA).
• Iron-deficient children received daily oral ferrous sulfate either immediately with antimalarials or delayed by 28 days.
• Children were monitored for 12 months, assessing hemoglobin, zinc protoporphyrin (ZPP), soluble transferrin receptor, and malaria incidence.

Main Results:

• Delayed iron treatment in children with SMA significantly reduced the prevalence of iron deficiency (ZPP levels) and soluble transferrin receptor concentrations after 12 months.
• No significant difference in hemoglobin concentration or malaria incidence was observed between immediate and delayed iron treatment groups.
• A trend towards fewer severe malaria episodes was noted in the SMA group receiving delayed iron.

Conclusions:

• In children with severe malarial anemia, delaying iron supplementation for 28 days after antimalarial treatment improves long-term iron status.
• This delayed approach does not negatively affect malaria incidence in the studied population.